MICAH DICKEY: Open Payments
NPI 1225290554 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 16 payments from 7 companies in 2025. Trend: 2023 $87 · 2024 $340 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $108 |
| Gilead Sciences, Inc. | 3 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| Lilly USA, LLC | 2 | $48 |
| Novo Nordisk Inc | 2 | $44 |
| PFIZER INC. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: JARDIANCE, EVENITY, MOUNJARO, OTEZLA, Repatha, PREVNAR 20, Wegovy, Ozempic.
Industry payments across CA — which companies pay providers there.
